MicroStockHub Moderna is down ~9% in early Monday afternoon trading, likely bringing an end to a 10-session winning streak that began on May 13. The decline comes after the company hit a 52-week high of $170.47 on May 24.
The intraday drop is the largest for Moderna since November 2023. The biotech has benefitted recently from bird flu fears . Moderna ( NASDAQ: MRNA ) shares are still up ~53% year to date.
More on Moderna Moderna: Betting On Bird Flu Rally Is A Poor Strategy For A Value Investor Aggressive Strides Forward For Moderna's Cancer Vaccine Moderna Q1: A Promising Pipeline Is Undervalued New COVID FLiRT variants spike as FDA delays key vaccine meeting Pfizer, Moderna in talks with HHS over avian flu vaccine: report (update).
